Sorafenib Alleviates Inflammatory Signaling of Tumor Microenvironment in Precancerous Lung Injuries

According to population-based studies, lung cancer is the prominent reason for cancer-related mortality worldwide in males and is also rising in females at an alarming rate. Sorafenib (SOR), which is approved for the treatment of hepatocellular carcinoma and renal cell carcinoma, is a multitargeted...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Betul Cicek, Ahmet Hacimuftuoglu, Mehmet Kuzucu, Ahmet Cetin, Yesim Yeni, Sidika Genc, Serkan Yildirim, Ismail Bolat, Mecit Kantarci, Mustafa Gul, Serhat Hayme, Dimitris Matthaios, Dimitra P. Vageli, Sotirios G. Doukas, Aristidis Tsatsakis, Ali Taghizadehghalehjoughi
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	MDPI AG 2023-02-01
Serie:	Pharmaceuticals
Soggetti:	lung carcinogenesis diethylnitrosamine inflammation SOX-2 COX-2 JNK
Accesso online:	https://www.mdpi.com/1424-8247/16/2/221
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!